Ysios Capital is a leading Spanish venture capital firm, providing private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions